ArticleEuropean journal of neurology2026
Tear Fluid Calcitonin Gene-Related Peptide Levels Are Elevated in Glycerol Trinitrate-Induced Cluster Headache Attacks: Results From an Exploratory Study.
Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCluster headache (CH) is a primary headache disorder characterized by severe, unilateral headache attacks accompanied by trigemino-autonomic symptoms. Calcitonin gene-related peptide (CGRP) is thought to be released during CH attacks, although the role of CGRP has been questioned. In this exploratory study, we investigated tear fluid CGRP levels during experimentally induced CH attacks using glycerol trinitrate.
methodsActive episodic and chronic CH patients were screened at study Day 1 and eligible patients received sublingual glycerol trinitrate 0.9 mg at study Day 2. Headache characteristics and tear fluid were sampled before and after intake of GTN. Tear fluid CGRP levels were analyzed using a commercial CGRP ELISA (Cusabio, Wuhan, China).
results89 episodic (eCH) and chronic cluster headache (cCH) patients were screened. Of these, 18 CH patients (eCH n = 11, 42.6 ± 10.0 years) were included in the analysis. Of 16 CH patients reported an experimentally induced CH attack, tear fluid CGRP levels significantly increased from "baseline" to "headache" ("baseline": 2.34 ± 3.22 ng/mL, "headache": 3.70 ± 5.60 ng/mL; p = 0.019). Tear fluid CGRP levels increased significantly more in participants with an intense headache attack (NRS ≥ 5: +2.65 ± 3.51 ng/mL) compared to participants with a mild intensity (NRS < 5: +0.07 ± 0.83 ng/mL, p = 0.015).
conclusionOur study results support the role of CGRP in the pathophysiology of CH. Further studies with a larger study sample and investigation of other neuropeptides are needed to better understand the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.